secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2022-03-04T23:59:59+00:00
Accession:  0001213900-22-010768
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx adopts 2022 Cash Bonus Plan; CCO salary $350k, GC $296k
------------------------------------------------------------------

- Compensation Committee adopted 2022 Cash Bonus Plan aligning officer pay with strategic goals.
- Stephen Silvestro (CCO) base salary increased to $350,000; bonus target set at 60% of base.
- Marion Odence-Ford (GC/Chief Compliance Officer) base salary $296,000; bonus target 40% of base.
- Employment agreements amended for both executives effective Feb 28, 2022, with eligibility for cash/equity incentives.
- Annual meeting scheduled for June 9, 2022; stockholder proposals due by March 14, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390022010768/0001213900-22-010768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390022010768/ea156483-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-010768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer